Safety and efficacy of a recombinant hepatitis E vaccine. - Wikidata - awgldk - TriplyDB

Safety and efficacy of a recombinant hepatitis E vaccine.

Safety and efficacy of a recombinant hepatitis E vaccine.

http://www.wikidata.org/entity/Q34002701

about

Health, human rights, and the conduct of clinical research within oppressed populations Hepatitis E epidemic, Uganda Acute liver failure including acetaminophen overdose Structure of the hepatitis E virus-like particle suggests mechanisms for virus assembly and receptor binding Enhanced immune stimulation by a therapeutic lymphoma tumor antigen vaccine produced in insect cells involves mannose receptor targeting to antigen presenting cells Hepatitis E virus as an emerging zoonotic pathogen Hepatitis Vaccines Hepatitis E virus infection: Epidemiology and treatment implications Current Knowledge on Hepatitis E Chronic hepatitis E: A brief review Hepatitis E, a vaccine-preventable cause of maternal deaths Lessons learned from successful human vaccines: Delineating key epitopes by dissecting the capsid proteins General Epidemiological Parameters of Viral Hepatitis A, B, C, and E in Six Regions of China: A Cross-Sectional Study in 2007 Molecular Biology and Infection of Hepatitis E Virus Acute Hepatitis E: Two Sides of the Same Coin Bats worldwide carry hepatitis E virus-related viruses that form a putative novel genus within the family Hepeviridae Evolution of the hepatitis E virus hypervariable region.Review article: hepatitis E-a concise review of virology, epidemiology, clinical presentation and therapy.Hepatitis E infection among Ghanaians: a systematic review Advances in hepatitis E - II: Epidemiology, clinical manifestations, treatment and prevention.Mutations within potential glycosylation sites in the capsid protein of hepatitis E virus prevent the formation of infectious virus particles.A Comprehensive Study of Neutralizing Antigenic Sites on the Hepatitis E Virus (HEV) Capsid by Constructing, Clustering, and Characterizing a Tool Box.Subduing the hepatitis E Python.Acute viral hepatitis morbidity and mortality associated with hepatitis E virus infection: Uzbekistan surveillance data Hepatitis E virus: animal reservoirs and zoonotic risk Time trend of the prevalence of hepatitis E antibodies among farmers and blood donors: a potential zoonosis in Denmark.Enteric hepatitis viruses.Hepatitis E-associated encephalopathy in a renal transplant recipient.Transmission, diagnosis, and management of hepatitis E: an update A systematic review of the epidemiology of hepatitis E virus in Africa.SPF rabbits infected with rabbit hepatitis E virus isolate experimentally showing the chronicity of hepatitis Hepatitis E Virus (HEV) strains in serum samples can replicate efficiently in cultured cells despite the coexistence of HEV antibodies: characterization of HEV virions in blood circulation.Subviral particle as vaccine and vaccine platform.Zoonotic hepatitis E: animal reservoirs and emerging risks Seroepidemiology of a second epidemic of hepatitis E in a population that had recorded first epidemic 30 years before and has been under surveillance since then.Outbreak of hepatitis E in urban Bangladesh resulting in maternal and perinatal mortality Hepatitis E virus ORF2 protein activates the pro-apoptotic gene CHOP and anti-apoptotic heat shock proteins Naturally occurring animal models of human hepatitis E virus infection.Molecular virology of hepatitis E virus.Novel risk factors associated with hepatitis E virus infection in a large outbreak in northern Uganda: results from a case-control study and environmental analysis.

P2860

Q24288922-86C632E7-D4B4-4395-A3F5-00CF5415D43B Q24609019-32E91C59-F3FB-4651-B9E2-866BEA721B3D Q24647134-E3326447-650C-499C-B8B7-DEEDD1D72EE8 Q24655874-189C010B-EF71-410E-9F3C-78CDA51E926C Q24658494-6D3BFFE5-C361-4D26-B80D-9D40F3AA4D53 Q26751267-CAF699FE-5155-4F9A-AC93-7BD9E20C031B Q26765433-41C57495-E6BB-4795-983E-C33FF5FAD901 Q26777044-F498C0B5-BA75-439E-B07E-70501A710669 Q26782030-6E719AB0-43B6-4EBC-A94D-9698426E1314 Q26784271-345263AF-124D-422E-A2EC-A3A035238A4D Q26852254-85CD2F15-E6D6-4280-86F0-544237A20E93 Q27013018-5244AB21-2415-4CD3-A91D-49454BFFB32C Q27490512-0920C088-A987-4475-8F1E-5879C4E9FE73 Q28066101-D16CB7C8-59D2-4B4F-944F-4D3FDC9F6AFF Q28069291-81E3570B-BEE1-43FC-9C1C-6F24D01267A2 Q28728496-EAA9F4B4-5BF0-4075-8A29-32E4B9F38961 Q30010037-59A2F596-81EB-457F-87B8-F98B7B5A5EE4 Q30234629-9C57281C-180A-42A4-902D-862CF2814892 Q30238550-623DD74E-7944-455E-8F2C-000421506402 Q30251421-0C0F2A1F-08AF-4CFF-BCA5-2ECC0B3A0863 Q30366046-8DF7AA00-FA7C-4450-B5F3-ECB2976B4FED Q30375781-DE0EC909-7F0B-49EB-9315-50EBEF46BE60 Q33369994-5C93EF16-5F60-439D-ACB4-1B3301A7A405 Q33422124-5B7B186E-9790-4413-A6BD-FE275C8E9CD0 Q33429348-641E4495-FC7B-4BE0-9AA8-124067C36C65 Q33577032-17CA5879-022F-482E-AC8E-166EE8ACE25F Q33596383-734DECD7-69C4-4FE3-81CD-19862DD42151 Q33629182-27EECF9A-3DB3-4906-911C-31B94967C8EB Q33734018-F2540D3B-C5EA-4C45-A567-903B72C31AED Q33747037-D126908C-BF30-4CC9-943C-F214FCF09842 Q33769042-5862EF39-E143-4456-BC7C-F7048B2BE723 Q33769640-D688FAA9-2E13-4C87-AE11-1295C0C6D367 Q33812653-82F84024-1D31-486A-A294-1A72E50FC11F Q33832118-FE17CF59-474B-4CF9-9AC7-21DEC9939F55 Q33977156-60FA21CB-6D6C-4935-9EE9-585A3ADBE8BC Q34034046-9DED71D8-3DA2-4C63-8DF7-7B9903AA9CBE Q34038276-0387822A-FCED-401C-9F84-2F3DB1AEFD55 Q34152290-152CFF14-6D95-447A-BF3D-63A52E6C1A3A Q34166393-8C0C5D53-37F4-45CE-B815-11F9FEFD0325 Q34240197-80A2A6BC-92CA-4DF0-A754-48FE8121AAA1

P2860

Safety and efficacy of a recombinant hepatitis E vaccine.

http://www.wikidata.org/entity/Q34002701

description

2007 nî lūn-bûn

@nan

2007 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի մարտին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Safety and efficacy of a recombinant hepatitis E vaccine.

@ast

Safety and efficacy of a recombinant hepatitis E vaccine.

@en

Safety and efficacy of a recombinant hepatitis E vaccine.

@nl

type

label

Safety and efficacy of a recombinant hepatitis E vaccine.

@ast

Safety and efficacy of a recombinant hepatitis E vaccine.

@en

Safety and efficacy of a recombinant hepatitis E vaccine.

@nl

prefLabel

Safety and efficacy of a recombinant hepatitis E vaccine.

@ast

Safety and efficacy of a recombinant hepatitis E vaccine.

@en

Safety and efficacy of a recombinant hepatitis E vaccine.

@nl

P1433

Q34002701-FAE0FF38-6596-44BF-A0CC-F4EE1A49E7F4

P1476

Q34002701-BC4E13DA-3000-45D5-B35A-58BC27C9918F

P2093

Q34002701-317EC00B-5092-4C98-9D9C-AA56C78733CF

Q34002701-31F4A921-E8AD-4B40-AB58-F3DFB6BADE28

Q34002701-3D22A898-EDA6-45EE-8AAE-4E8CB25E5E6A

Q34002701-52C8CDB8-F68F-44BE-9405-27F9F25A6308

Q34002701-534A71D2-832D-4438-ADC2-01E0C9B33BB3

Q34002701-68EFEDCF-D4F5-4B34-AD9C-8CBE26CB9BCD

Q34002701-6961C918-1868-4C6D-96F8-2C6EC8305CBD

Q34002701-79458533-766A-4795-8420-6B3642EA292F

Q34002701-7A2FB475-70B1-4CC8-9B2E-E48FD821ECAF

Q34002701-87CCB3D9-46C9-4711-AB4F-0F240BE199A1

P304

Q34002701-1C5167DD-0728-40C4-84C0-C67CA6572F74

P31

Q34002701-0C0EE980-4074-44C2-BEBD-39CB65ED411C

P356

Q34002701-717E2860-04EB-44EA-A5B3-94D8A006ED5D

P407

Q34002701-90A7E4BA-433C-43EA-BF14-B3FC1B2F4F19

P433

Q34002701-74C46078-F75C-4592-9136-2508D46914A4

P478

Q34002701-DDEEC410-43EB-4EC4-9AD2-E733731F90B4

P577

Q34002701-A35E274E-0898-4C93-9F31-E784DE4E46BE

P698

Q34002701-C840AAE2-EB59-413F-8323-9F31CE926CD0

P356

P1433

The New England Journal of Medicine

P1476

Safety and efficacy of a recombinant hepatitis E vaccine.

@en

P2093

Assad Safary

http://www.w3.org/2001/XMLSchema#string

Bruce L Innis

http://www.w3.org/2001/XMLSchema#string

David W Vaughn

http://www.w3.org/2001/XMLSchema#string

Durga Man Joshi

http://www.w3.org/2001/XMLSchema#string

Gyan Bahadur Thapa

http://www.w3.org/2001/XMLSchema#string

Jitvimol Seriwatana

http://www.w3.org/2001/XMLSchema#string

Khin Saw Aye Myint

http://www.w3.org/2001/XMLSchema#string

Mammen P Mammen

http://www.w3.org/2001/XMLSchema#string

Marc Fourneau

http://www.w3.org/2001/XMLSchema#string

Marie Pierre David

http://www.w3.org/2001/XMLSchema#string

P304

895-903

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA061847

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

356

http://www.w3.org/2001/XMLSchema#string

P577

2007-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17329696

http://www.w3.org/2001/XMLSchema#string